Back
Arcus Biosciences Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
77
RCUS
Arcus Biosciences
Last Price:
17.85
Seasonality Move:
12.52%
Buy
64
ITCI
Intra-Cellular Therapies
Last Price:
91.34
Seasonality Move:
17.18%
Buy
77
Arcus Biosciences (RCUS)
is a Buy
Is Arcus Biosciences a Buy, Sell or Hold?
- The current Arcus Biosciences [RCUS] share price is $17.85. The Score for RCUS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- RCUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $91.36. The Score for ITCI is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCUS Stock Price Chart
What is Arcus Biosciences's stock price today?
-
The Arcus Biosciences share price today is $17.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $91.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 59.43 | Buy |
| Chaikin Money Flow: | 1017345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.95 - 17.87) | Buy |
| Bollinger Bands (100): | (14.85 - 17.23) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.14 | Buy |
| Relative Strength Index (14 RSI): | 79.48 | Buy |
| Chaikin Money Flow: | 485413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.84 - 85.52) | Buy |
| Bollinger Bands (100): | (71.56 - 80.3) | Buy |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.96 | Buy |
| 20-day SMA: | 16.83 | Buy |
| 50-day SMA: | 16.59 | Buy |
| 200-day SMA: | 16.36 | Buy |
| 8-day EMA: | 16.4 | Buy |
| 20-day EMA: | 16.49 | Buy |
| 50-day EMA: | 16.49 | Buy |
| 200-day EMA: | 16.59 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.93 | Buy |
| 20-day SMA: | 80.81 | Buy |
| 50-day SMA: | 76.65 | Buy |
| 200-day SMA: | 72.42 | Buy |
| 8-day EMA: | 87.42 | Buy |
| 20-day EMA: | 82.58 | Buy |
| 50-day EMA: | 78.44 | Buy |
| 200-day EMA: | 72.33 | Buy |
Arcus Biosciences Earnings Growth & RCUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.54 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.
Arcus Biosciences Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||